Effectiveness of Botulinum Toxin Type A for Trichodynia Associated with Hair Loss Disorders: A Retrospective Study - Summary - MDSpire

Effectiveness of Botulinum Toxin Type A for Trichodynia Associated with Hair Loss Disorders: A Retrospective Study

  • By

  • David Saceda-Corralo

  • Adrián Imbernon-Moya

  • Juan Jiménez-Cauhe

  • Cristina Pindado-Ortega

  • Valentina Balaguera-Orjuela

  • Patricia Burgos-Blasco

  • Amparo Guillem

  • Rocío Gil-Redondo

  • Sergio Vañó-Galván

  • June 24, 2026

  • 0 min

Share

Objective:

To explore the therapeutic potential of intradermal botulinum toxin type A (BTA) for trichodynia unresponsive to conventional therapies in patients with different hair loss conditions.

Approach:
  • Study Design: A retrospective study assessing the effectiveness and safety of intradermal BTA in patients with trichodynia associated with hair disorders.
  • Patient Selection: Patients who declined or discontinued systemic oral therapies for symptomatic control were included.
  • Treatment Administration: BTA was administered as off-label therapy via intradermal injections using the Nappage technique.
Key Findings:
  • Intradermal BTA demonstrated rapid, significant, and sustained reduction of trichodynia severity in patients with cicatricial alopecias.
  • Minimal adverse effects were reported in patients treated with BTA.
Interpretation:

Limitations:
  • The study is retrospective, which may introduce bias.
  • The sample size and diversity of hair loss conditions were not specified.
Conclusion:

Original Source(s)

Related Content